[Federal Register Volume 67, Number 69 (Wednesday, April 10, 2002)]
[Notices]
[Page 17417]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-8677]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Method of Diagnosing 
Stage or Aggressive of Breast and Prostate Cancer Based on Levels of 
Fatty Acids Binding Proteins

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application No. 09/451,513 
entitled ``Method of Diagnosing Stage or Aggressiveness of Breast and 
Prostate Cancer Based on Levels of Fatty Acids Binding Proteins'' filed 
Nov. 30, 1999. Foreign rights are also available (PCT/US99/28314), 
filed Nov. 30, 1999. The United States Government as represented by the 
Secretary of the Army has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A method of diagnosing the stage or 
aggressiveness of cancer and particularly breast and prostate cancer by 
measuring the deviation of levels of fatty acid binding proteins in 
mammalian tissue or body fluids from normal levels of fatty acid 
binding proteins. The invention relates to a family of key proteins 
levels of fatty acid binding proteins. The invention relates to a 
family of key proteins called fatty acid binding proteins, which are 
involved in metabolism of AA and other lipids and how they affect the 
proliferation of cancer cells.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-8677 Filed 4-9-02; 8:45 am]
BILLING CODE 3710-08-M